Riskpilot← Back to searchSign inGet full accessSKAN-MEDIC ApS
APSActiveCVR 89890411Adelgade 27Manufacture of perfumes and toilet preparations · NACE 2042Est. 19824 employees
Revenue 2025
DKK 1,5M
-38% vs 2024
EBITDA margin
87.9%
-43% vs 2024
Equity ratio
82.1%
Financial strength
Net profit 2025
DKK 990K
-48% vs 2024
| Revenue | DKK 1,5M | -38% |
| EBITDA | DKK 1,3M | -43% |
| Net profit | DKK 990K | -48% |
| Total assets | DKK 3,9M | -25% |
| Equity | DKK 3,2M | -24% |
| Employees | 4 | — |
Legal name
SKAN-MEDIC ApS
CVR number
89890411
Legal form
Anpartsselskab
NACE code
2042 · Manufacture of perfumes and toilet preparations
Founded
10. januar 1982
Share capital
DKK 200.000
Employees
4 (FTE)
VAT registered
Yes
Audit selected
Yes
Last report
2025-12-31
Financial year
January – December
Signatory rights
Selskabet tegnes af en direktør i forening med
bestyrelsesformanden eller af den samlede bestyrelse i forening
Company purpose
Selskabets formål er fabrikation, handel og distribution af cremer, pastaer, salver, linimenter og lignende produkter
Address
Adelgade 27
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 3.188 | 2.830 | 2.950 | 2.702 | 2.413 | 2.588 | 2.511 | 2.065 | 2.619 | 2.000 | 2.135 | 2.556 | 2.359 | 1.453 |
| Staff expenses | -1.522 | -1.383 | -1.227 | -1.127 | -0 | -0 | -0 | -1.182 | -1.403 | -0 | -0 | -0 | -0 | -0 |
| EBITDA | 3.017 | 2.658 | 2.666 | 2.442 | 2.140 | 2.313 | 2.242 | 2.006 | 2.564 | 1.932 | 2.071 | 2.463 | 2.255 | 1.276 |
| Depreciation & amort. | -101 | -101 | -1 | -1 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 |
| EBIT | 2.917 | 2.557 | 2.665 | 2.441 | 2.140 | 2.313 | 2.242 | 2.006 | 2.564 | 1.932 | 2.071 | 2.463 | 2.255 | 1.276 |
| Net financials | 163 | 352 | 234 | -355 | 651 | -72 | -581 | 1.270 | 1.224 | 6.562 | -258 | 125 | 170 | -7 |
| Profit before tax | 3.080 | 2.909 | 2.899 | 2.086 | 2.791 | 2.241 | 1.661 | 3.275 | 3.788 | 8.494 | 1.813 | 2.588 | 2.425 | 1.269 |
| Tax | 731 | 652 | 712 | 491 | 488 | 493 | 366 | 715 | 833 | 1.869 | 399 | 569 | 533 | 279 |
| Net profit | 2.349 | 2.257 | 2.187 | 1.595 | 2.303 | 1.748 | 1.295 | 2.560 | 2.955 | 6.626 | 1.414 | 2.019 | 1.891 | 990 |
| Item | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total assets | 5.805 | 6.742 | 6.736 | 6.266 | 6.663 | 6.885 | 7.537 | 8.913 | 11.288 | 15.986 | 6.028 | 6.125 | 5.277 | 3.948 |
| Equity | 4.900 | 5.157 | 6.344 | 5.939 | 6.242 | 5.989 | 5.285 | 7.845 | 10.799 | 15.425 | 4.840 | 5.358 | 4.250 | 3.240 |
| Long-term debt | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Short-term debt | 905 | 1.585 | 392 | 327 | 421 | 896 | 2.252 | 1.068 | 489 | 561 | 1.188 | 767 | 1.027 | 707 |
| Total debt | 905 | 1.585 | 392 | 327 | 421 | 896 | 2.252 | 1.068 | 489 | 561 | 1.188 | 767 | 1.027 | 707 |
EBITDA margin
87.9%
This company
15.8%
Market median
+456% vs market
20122025
Equity ratio
82.1%
This company
38.2%
Market median
+115% vs market
20122025
Return on equity
30.6%
This company
18.4%
Market median
+66% vs market
20122025
Net profit margin
68.1%
This company
8.1%
Market median
+741% vs market
20122025
Asset turnover
0.37×
This company
1.12×
Market median
-67% vs market
20122025
Debt / equity
0.22×
This company
0.62×
Market median
+65% vs market
20122025
- Annual report 2025Filed via CVR / Virk · Period 2025-01-01 – 2025-12-31
- Annual report 2024Filed via CVR / Virk · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via CVR / Virk · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via CVR / Virk · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via CVR / Virk · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via CVR / Virk · Period 2020-01-01 – 2020-12-31
- Annual report 2019Filed via CVR / Virk · Period 2019-01-01 – 2019-12-31
- Annual report 2018Filed via CVR / Virk · Period 2018-01-01 – 2018-12-31
- Annual report 2017Filed via CVR / Virk · Period 2017-01-01 – 2017-12-31
- Annual report 2016Filed via CVR / Virk · Period 2016-01-01 – 2016-12-31
- Annual report 2015Filed via CVR / Virk · Period 2015-01-01 – 2015-12-31
- Annual report 2014Filed via CVR / Virk · Period 2014-01-01 – 2014-12-31
- Annual report 2013Filed via CVR / Virk · Period 2013-01-01 – 2013-12-31
- Annual report 2012Filed via CVR / Virk · Period 2012-01-01 – 2012-12-31
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
| Audit | 1982 | — | — | |
SR Management | Management | 2023 | — | — |
AR Management | Management | 1982 | — | — |
HA Audit | Audit | 1982 | — | — |
LW Management | Management | 2025 | — | — |
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
JD | Chairman | 2025 | — | — |
| Board of Directors | 2025 | — | — | |
| Board of Directors | 1982 | — | — |
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
BESULA ApS | Company | 100.0% | 100.0% | 2006 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
JDA-Invest ApS
SKAN-MEDIC ApS Board members of SKAN-MEDIC ApS also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Revisorinteressentskabet Midtgaard & Hübertz | Audit | 0 companies |
| Susanne Rasmussen | Management | 0 companies |
| Aage Rasmussen | Management | 0 companies |
| Hans Anker Nielsen | Audit | 0 companies |
| Line Wulff | Management | 0 companies |
| Jan Dam | Chairman | 0 companies |
| Kent Ernst Hansen | Board of Directors | 0 companies |
| Judy Rasmussen | Board of Directors | 0 companies |